摘要
葡萄膜炎是指一些可导致失明的眼炎症性疾病。多年来,研究人员一直试图采用实验性自身免疫性葡萄膜炎(EAU)模型来破译其潜在发病机制并开发治疗方案。最近,已发现αA-晶状体在EAU中上调,甚至可以通过不同机制改善其严重程度,这一发现表明αA-晶状体是葡萄膜炎一个有效的治疗因素。本文综述了αA晶状体的保护作用,并讨论其在EAU中的作用机制。
关键词: αA晶状,实验性自身免疫性葡萄膜炎,基因治疗,葡萄膜炎。
Current Molecular Medicine
Title:The Role of αA-Crystallin in Experimental Autoimmune Uveitis
Volume: 15 Issue: 6
Author(s): L. Wang, L. Zhang, Z.-F. Wang, Z.-X. Huang, X. Hu, L. Gong, X. Tang, F. Liu, Z. Luo and W. Ji, W.-F. Hu, Z. Woodward, J. Zhu, Y.-Z. Liu, Q.D. Nguyen and D.W.-C. Li
Affiliation:
关键词: αA晶状,实验性自身免疫性葡萄膜炎,基因治疗,葡萄膜炎。
摘要: Uveitis refers to a group of ocular inflammatory diseases that can lead to blindness. For years, researchers have been trying to decipher the underlying mechanisms and develop therapeutic strategies using the model of experimental autoimmune uveitis (EAU). Recently, αA-crystallin has been found to be upregulated in EAU and can even ameliorate its severity through different mechanisms, suggesting its use as a potent therapeutic factor against uveitis. Here we review the protective role of αA-crystallin and discuss its functional mechanisms in EAU.
Export Options
About this article
Cite this article as:
L. Wang, L. Zhang, Z.-F. Wang, Z.-X. Huang, X. Hu, L. Gong, X. Tang, F. Liu, Z. Luo and W. Ji, W.-F. Hu, Z. Woodward, J. Zhu, Y.-Z. Liu, Q.D. Nguyen and D.W.-C. Li , The Role of αA-Crystallin in Experimental Autoimmune Uveitis, Current Molecular Medicine 2015; 15 (6) . https://dx.doi.org/10.2174/1566524015666150731101146
DOI https://dx.doi.org/10.2174/1566524015666150731101146 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Metabotropic Glutamate Receptors and Interacting Proteins: Evolving Drug Targets
Current Drug Targets C. elegans as a Genetic Model System to Identify Parkinson's Disease- Associated Therapeutic Targets
CNS & Neurological Disorders - Drug Targets Neuroprotection by Association of Palmitoylethanolamide with Luteolin in Experimental Alzheimer’s Disease Models: The Control of Neuroinflammation
CNS & Neurological Disorders - Drug Targets Applications of Current Proteomics Techniques in Modern Drug Design
Current Computer-Aided Drug Design In Vivo Application of beta Amyloid Oligomers: A Simple Tool to Evaluate Mechanisms of Action and New Therapeutic Approaches
Current Pharmaceutical Design Conantokins Inhibitors of Ion Flow through the N-Methyl-D-Aspartate Receptor Channels
Current Drug Targets Antiinflammatory Activity of Melatonin in Central Nervous System
Current Neuropharmacology Non-Selective Cation Channel Blockers: Potential Use in Nervous System Basic Research and Therapeutics
Mini-Reviews in Medicinal Chemistry Retinoic Acid Induced 1, RAI1: A Dosage Sensitive Gene Related to Neurobehavioral Alterations Including Autistic Behavior
Current Genomics Pharmaceutical Targeting of the Brain
Current Pharmaceutical Design Editorial (Thematic Issue: New Therapeutic Bearings for Repositioned Drugs)
Current Topics in Medicinal Chemistry The Role of Ketamine in Treatment-Resistant Depression: A Systematic Review
Current Neuropharmacology Blockers of Voltage-Gated Sodium Channels for the Treatment of Central Nervous System Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Current Nervous System Related Drug Targets for the Treatment of Amyotrophic Lateral Sclerosis
Current Pharmaceutical Design The Many Roles of Chemokine Receptors in Neurodegenerative Disorders: Emerging New Therapeutical Strategies
Current Medicinal Chemistry Curcuminoids in Neurodegenerative Diseases
Recent Patents on CNS Drug Discovery (Discontinued) A Multicenter, Double-Blind, Placebo-Controlled Trial of the PDE9A Inhibitor, PF-04447943, in Alzheimer's Disease
Current Alzheimer Research Asymmetric Dimethylarginine: A Possible Link between Vascular Disease and Dementia
Current Alzheimer Research Editorial (Thematic Issue: Neurodegeneration, Oxidative Stress, Metabolic Syndrome, Drug Design and Development: Clinical Implications)
CNS & Neurological Disorders - Drug Targets Apoptosis: A Key in Neurodegenerative Disorders
Current Neurovascular Research